By Dr Thomas James Santo Jr

Journal articles

Economidis G; Lynch M; Taylor S; Asare-Doku W; Macpherson G; Degenhardt L; Farrell M; Santo T, 2025, 'Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations', Drug and Alcohol Review, 44, pp. 1601 - 1640, http://dx.doi.org/10.1111/dar.14080

Santo TJ; Chaillon A; Martin N; Hickman M; Jones N; Farrell M; Bharat C; Degenhardt L; Borquez A, 2025, 'Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study', Addiction, 120, pp. 1601 - 1609, http://dx.doi.org/10.1111/add.70018

Jones N; Ghouse FN; Gibson A; Tran DT; Santo T; Bharat C; Farrell M; Degenhardt L, 2025, 'Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia', International Journal of Epidemiology, 54, http://dx.doi.org/10.1093/ije/dyaf037

Santo T; Degenhardt L, 2025, 'INJECTING DRUG USE AND BLOOD-BORNE VIRUS DISEASE IN PRISON SETTINGS: PREVALENCE, TREATMENT COVERAGE, AND LONG-TERM HEALTH AND SOCIAL OUTCOMES', DRUG AND ALCOHOL DEPENDENCE, 267, http://dx.doi.org/10.1016/j.drugalcdep.2024.112364

Santo T; Chaillon A; Martin N; Bharat C; Jones N; Farrell M; Hickman M; Borquez A; Degenhardt L, 2025, 'Quantifying the Impact of Opioid Agonist Treatment on Suicide Mortality in New South Wales, Australia: A Population-Level Analysis from 2001 to 2020', DRUG AND ALCOHOL DEPENDENCE, 267, http://dx.doi.org/10.1016/j.drugalcdep.2024.112133

Jones N; Santo Jr T; Gibson A; Lappin J; Lintzeris N; Degenhardt L; Larney S; Gisev N, 2025, 'The Impact of Severe Mental Illness on Treatment Retention and All-Cause Mortality of Individuals in Opioid Agonist Treatment: A Retrospective Data Linkage Study', DRUG AND ALCOHOL DEPENDENCE, 267, pp. 262 - 262, http://dx.doi.org/10.1016/j.drugalcdep.2024.112015

Leung J; Lim C; Sun T; Vu G; McClure-Thomas C; Bao Y; Tran L; Santo T; Fausiah F; Farassania G; Chan GCK; Sebayang SK, 2024, 'Preventable Deaths Attributable to Second-Hand Smoke in Southeast Asia—Analysis of the Global Burden of Disease Study 2019', International Journal of Public Health, 69, http://dx.doi.org/10.3389/ijph.2024.1606446

Santo T; Gisev N; Campbell G; Colledge-Frisby S; Wilson J; Tran LT; Lynch M; Martino-Burke D; Taylor S; Degenhardt L, 2024, 'Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis.', Int J Drug Policy, 128, pp. 104434, http://dx.doi.org/10.1016/j.drugpo.2024.104434

Santo T, 2023, 'Errors in Data Reported in Meta-Analysis on Opioid Agonist Treatment and Mortality', JAMA Psychiatry, 80, pp. 971 - 972, http://dx.doi.org/10.1001/jamapsychiatry.2023.2342

Colledge-Frisby S; Jones N; Degenhardt L; Hickman M; Padmanathan P; Santo T; Farrell M; Gisev N, 2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851

Santo T; Gisev N; Campbell G; Nelson E; Degenhardt L, 2023, 'The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence', Drug and Alcohol Dependence, 243, http://dx.doi.org/10.1016/j.drugalcdep.2022.109734

Santo Jr T; Clark B; Hickman M, 2023, 'Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis (vol 78, pg 979, 2021)', JAMA PSYCHIATRY, 80, pp. 972 - 972, http://dx.doi.org/10.1001/jamapsychiatry.2023.2537

Santo T; Campbell G; Gisev N; Martino-Burke D; Wilson J; Colledge-Frisby S; Clark B; Tran LT; Degenhardt L, 2022, 'Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109551

Leung J; Santo T; Colledge-Frisby S; Mekonen T; Thomson K; Degenhardt L; Connor JP; Hall W; Stjepanović D, 2022, 'Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies', Pain Medicine United States, 23, pp. 1442 - 1456, http://dx.doi.org/10.1093/pm/pnac029

Zahra E; Chen R; Nielsen S; Tran AD; Santo T; Degenhardt L; Farrell M; Byrne J; Ali R; Larance B, 2022, 'Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients', Drug and Alcohol Review, 41, pp. 841 - 850, http://dx.doi.org/10.1111/dar.13437

Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103472

Santo T; Campbell G; Gisev N; Degenhardt L, 2022, 'Exposure to childhood trauma increases risk of opioid use disorder among people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Dependence, 230, http://dx.doi.org/10.1016/j.drugalcdep.2021.109199

Santo T; Clark B; Hickman M, 2022, 'Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis (vol 78, pg 979, 2021)', JAMA PSYCHIATRY, 79, pp. 516 - 516, http://dx.doi.org/10.1001/jamapsychiatry.2022.0357

Santo T; Clark B; Hickman M; Grebely J; Campbell G; Sordo L; Chen A; Tran LT; Bharat C; Padmanathan P; Cousins G; Dupouy J; Kelty E; Muga R; Nosyk B; Min J; Pavarin R; Farrell M; Degenhardt L, 2021, 'Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of Death among People with Opioid Dependence: A Systematic Review and Meta-analysis', JAMA Psychiatry, 78, pp. 979 - 993, http://dx.doi.org/10.1001/jamapsychiatry.2021.0976

Grebely J; Tran L; Degenhardt L; Dowell-Day A; Santo T; Larney S; Hickman M; Vickerman P; French C; Butler K; Gibbs D; Valerio H; Read P; Dore GJ; Hajarizadeh B, 2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612

Ferraro CF; Stewart DE; Grebely J; Tran LT; Zhou S; Puca C; Hajarizadeh B; Larney S; Santo T; Higgins JPT; Vickerman P; Degenhardt L; Hickman M; French CE, 2021, 'Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis', Addiction, 116, pp. 1664 - 1676, http://dx.doi.org/10.1111/add.15316

Peacock A; Tran LT; Larney S; Stockings E; Santo T; Jones H; Santomauro D; Degenhardt L, 2021, 'All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis', Addiction, 116, pp. 725 - 742, http://dx.doi.org/10.1111/add.15239

Santo T; Campbell G; Gisev N; Tran LT; Colledge S; Di Tanna GL; Degenhardt L, 2021, 'Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108459

Santo T; Clark B; Hickman M, 2021, 'Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis (Jun, 10.1001/jamapsychiatry.2021.0976, 2021)', JAMA PSYCHIATRY, 78, pp. 1044 - 1044, http://dx.doi.org/10.1001/jamapsychiatry.2021.1754

Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M, 2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941

Larney S; Tran LT; Leung J; Santo T; Santomauro D; Hickman M; Peacock A; Stockings E; Degenhardt L, 2020, 'All-Cause and Cause-Specific Mortality among People Using Extramedical Opioids: A Systematic Review and Meta-analysis', JAMA Psychiatry, 77, pp. 493 - 502, http://dx.doi.org/10.1001/jamapsychiatry.2019.4170

Santo T; Larance B; Bruno R; Gisev N; Nielsen S; Degenhardt L; Campbell G, 2020, 'Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain', Drug and Alcohol Review, 39, pp. 128 - 134, http://dx.doi.org/10.1111/dar.13021

Larney S; Peacock A; Tran LT; Stockings E; Santomauro D; Santo T; Degenhardt L, 2020, 'All-Cause and Overdose Mortality Risk among People Prescribed Opioids: A Systematic Review and Meta-analysis', Pain Medicine United States, 21, pp. 3700 - 3711, http://dx.doi.org/10.1093/PM/PNAA214

Tran A; Larance LB; Santo T; Economidis G, 2020, 'PDG62 HEALTH STATE UTILITIES OF PEOPLE WHO USE OPIOIDS REGURLARLY IN NEW SOUTH WALES, VICTORIA AND TASMANIA, AUSTRALIA: ARE THEY RELATED TO DRUG HISTORY AND OPIOID SUBSTITUTION THERAPY?', Value in Health, 23, pp. S140 - S140, http://dx.doi.org/10.1016/j.jval.2020.04.348

Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine United States, 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009

Stockings E; Tran LT; Santo T; Peacock A; Larney S; Santomauro D; Farrell M; Degenhardt L, 2019, 'Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis', Addiction, 114, pp. 1738 - 1750, http://dx.doi.org/10.1111/add.14706

Lintzeris N; Santo T; Nielsen S; Degenhardt L; Campbell G, 2019, 'Estimating Centre for Disease Control and Prevention-defined overdose risk in people prescribed opioids for chronic non-cancer pain: implications for take-home naloxone provision', Internal Medicine Journal, 49, pp. 1054 - 1055, http://dx.doi.org/10.1111/imj.14386

Back to profile page